Emergency vaccination of sheep against foot-and-mouth disease: significance and detection of subsequent sub-clinical infection.

This study has quantified the level of foot-and-mouth disease virus (FMDV) replication and shedding in vaccinated sheep and correlated this to the severity of clinical signs, the induction of antibodies against FMDV non-structural proteins (NSPs) and the transmission of virus to in-contact vaccinated sentinel sheep. To mimic an emergency vaccination regime in the field, sheep were vaccinated with O(1) Manisa vaccine and 4 or 10 days later were indirectly challenged with aerosols from O(1) UKG FMDV infected pigs. Vaccinated and control unvaccinated sheep were monitored for a minimum of 39 days post-challenge. The vaccinated sheep became sub-clinically infected, with reduced virus replication and excretion compared to unvaccinated and clinically infected sheep. Seroconversion to NSP was weak and transient in sheep in which virus replication was of low level and short duration. Virus transmission from vaccinated sub-clinically infected sheep to introduced vaccinated sentinels was not sufficient to cause NSP seroconversion or significant virus shedding. 10% of 10 days and 20% of 4 days vaccinated sheep were virus carriers at greater than 28 days post-challenge compared to 37.5% in the unvaccinated and clinically infected sheep. These results suggest that the low levels of virus replication likely if an effective vaccine is administered at least 4 days prior to challenge exposure are unlikely to result in the spread of infection even under intensive management conditions. Although it may be difficult to detect this infection by serosurveillance, the significance of missing it is likely to be low and the main value of such testing will be to detect undisclosed clinical infection resulting from lack of observation or from exposure to virus before or very soon after vaccination or from vaccine failure due to maladministration or inappropriate strain selection.

[1]  C. M. Hendrix Manual of Standards for Diagnostic Tests and Vaccines , 1997 .

[2]  Y. Leforban Prevention measures against foot-and-mouth disease in Europe in recent years. , 1999, Vaccine.

[3]  R. Kitching A recent history of foot-and-mouth disease. , 1998, Journal of comparative pathology.

[4]  W. B.,et al.  Foot and mouth disease. , 2002, Research in veterinary science.

[5]  S. Reid,et al.  Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge. , 2007, Vaccine.

[6]  Valerie Mioulet,et al.  Serial passage of foot-and-mouth disease virus in sheep reveals declining levels of viraemia over time. , 2002, The Journal of general virology.

[7]  J. Sánchez-Vizcaíno,et al.  Serological evidence of FMD subclinical infection in sheep population during the 1999 epidemic in Morocco. , 2002, Veterinary microbiology.

[8]  Zhidong Zhang,et al.  Aspects of the persistence of foot-and-mouth disease virus in animals--the carrier problem. , 2002, Microbes and infection.

[9]  A Bouma,et al.  Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. , 2004, Vaccine.

[10]  M C M de Jong,et al.  Quantification of foot and mouth disease virus excretion and transmission within groups of lambs with and without vaccination. , 2007, Vaccine.

[11]  J. Wilesmith,et al.  Modelling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination , 2008, Proceedings of the Royal Society B: Biological Sciences.

[12]  A. Donaldson,et al.  Exposure of sheep to natural aerosols of foot-and-mouth disease virus. , 1986, Research in veterinary science.

[13]  D. Mackay,et al.  Detection of antibody to the foot-and-mouth disease virus (FMDV) non-structural polyprotein 3ABC in sheep by ELISA. , 2005, Journal of virological methods.

[14]  S. Gubbins,et al.  Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge. , 2007, Vaccine.

[15]  R. Kitching,et al.  Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom. , 2002, Vaccine.

[16]  M. Dawson,et al.  Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. , 1988, Veterinary microbiology.

[17]  S. Alexandersen,et al.  Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs , 2002, Epidemiology and Infection.

[18]  P. Barnett,et al.  The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease. , 1999, Veterinary journal.

[19]  E O Powell,et al.  A cyclone separator for aerosol sampling in the field , 1969, Journal of Hygiene.

[20]  W. Snowdon Growth of Foot-and-Mouth Disease Virus in Monolayer Cultures of Calf Thyroid Cells , 1966, Nature.

[21]  M. Oleksiewicz,et al.  The early pathogenesis of foot-and-mouth disease in pigs infected by contact: a quantitative time-course study using TaqMan RT-PCR. , 2001, The Journal of general virology.

[22]  J. Horsington,et al.  Foot-and-mouth disease virus crosses the placenta and causes death in fetal lambs. , 2007, Journal of comparative pathology.

[23]  S. Alexandersen,et al.  Determinants of early foot-and-mouth disease virus dynamics in pigs. , 2004, Journal of comparative pathology.

[24]  M. Ganter,et al.  [Foot and mouth disease in sheep and goats]. , 2001, DTW. Deutsche tierarztliche Wochenschrift.

[25]  M. Greiner,et al.  Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. , 2006, Vaccine.

[26]  Christl A. Donnelly,et al.  The Foot-and-Mouth Epidemic in Great Britain: Pattern of Spread and Impact of Interventions , 2001, Science.

[27]  J. Salt,et al.  Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. , 1998, Vaccine.

[28]  R. Burrows The persistence of foot-and-mouth disease virus in sheep , 1968, Epidemiology and Infection.

[29]  W. Vosloo,et al.  Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC. , 2004, Veterinary microbiology.

[30]  J. Bayry,et al.  Immune Responses of Sheep to Quadrivalent Double Emulsion Foot-and-Mouth Disease Vaccines: Rate of Development of Immunity and Variations among Other Ruminants , 2002, Journal of Clinical Microbiology.

[31]  A. Donaldson,et al.  Foot-and-mouth disease: the risk for Great Britain after 1992 , 1992, Veterinary Record.

[32]  W. A. Geering FOOT‐AND‐MOUTH DISEASE IN SHEEP , 1967 .

[33]  K. R. May,et al.  The Efficiency of Various Liquid Impinger Samplers in Bacterial Aerosols , 1957, British journal of industrial medicine.

[34]  M. Greiner,et al.  Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. , 2006, Vaccine.

[35]  R. Sellers,et al.  The airborne dispersal of foot-and-mouth disease virus from vaccinated and recovered pigs, cattle and sheep after exposure to infection. , 1977, Research in veterinary science.

[36]  B. Baxt,et al.  Foot-and-Mouth Disease , 2004, Clinical Microbiology Reviews.

[37]  Kitching Rp,et al.  Clinical variation in foot and mouth disease: sheep and goats. , 2002 .

[38]  S. Alexandersen,et al.  Natural aerosol transmission of foot-and-mouth disease virus to pigs: minimal infectious dose for strain O1 Lausanne , 2002, Epidemiology and Infection.

[39]  Zhidong Zhang,et al.  Detection of carrier cattle and sheep persistently infected with foot-and-mouth disease virus by a rapid real-time RT-PCR assay. , 2003, Journal of virological methods.

[40]  Zhidong Zhang,et al.  Quantities of infectious virus and viral RNA recovered from sheep and cattle experimentally infected with foot-and-mouth disease virus O UK 2001. , 2002, The Journal of general virology.

[41]  S. Reid,et al.  Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep. , 2004, Vaccine.

[42]  K. Sorensen,et al.  Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus , 1998, Archives of Virology.

[43]  R. Kitching,et al.  Clinical variation in foot and mouth disease: sheep and goats. , 2002, Revue scientifique et technique.